ARCHIVES

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

December 12, 1980

NCI Makes Its Pitch To OMB For Its First Billion Dollar Budget; Research Areas Listed By Priority

October 14, 1977

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997